Product

Antidepressant therapy

1 clinical trial

1 indication

Indication

Major Depressive Disorder

Clinical trial

A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy, Safety, and Tolerability of Brexpiprazole as Adjunctive Therapy in the Maintenance Treatment of Adults With Major Depressive Disorder

Status: Completed, Estimated PCD: 2022-07-08